{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:17:09Z","timestamp":1789204629710,"version":"build-2803163510"},"reference-count":46,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatitis delta virus (HDV) infection causes the severest form of viral hepatitis in humans. Discovered in 1977, it was considered an infection prevalent in the eastern Mediterranean region. Today it is recognized as a global infection of public health importance, however accurate prevalence remains uncertain because of lack of good epidemiological studies. Under\u2010screening for HDV is the single most important factor in under\u2010estimating the true burden of infection. Urgent efforts are therefore needed to apply reliable screening tools and robust surveillance methodologies to study HDV. There is now a move by major hepatology societies to recommend HDV antibody testing in all persons with HBV infection. Important differences also need to be recognized between countries considered endemic or non\u2010endemic countries. While the endemic infections likely spread horizontally in the general population, and is quite often nosocomial, in non\u2010endemic countries special populations may carry the greater burden, such as persons with injection drug use and various sexual exposures. Even in endemic countries, HDV often exists in significant pockets of the general population. HDV has been categorized as an orphan infection due to lack of approved therapies. Recently there have significant advances in therapy and further clinical trials continue. However, as new therapies are approved, equitable access to the medications will become a major public health issue, particularly because most HDV patients live in low or low middle income countries.<\/jats:p>","DOI":"10.1111\/liv.15579","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T01:43:48Z","timestamp":1682127828000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Elimination of\n                    <scp>HDV<\/scp>\n                    : Epidemiologic implications and public health perspectives"],"prefix":"10.1111","volume":"43","author":[{"given":"Areeba","family":"Tharwani","sequence":"first","affiliation":[{"name":"Department of Medicine Aga Khan University  Karachi Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7218-6885","authenticated-orcid":false,"given":"Saeed","family":"Hamid","sequence":"additional","affiliation":[{"name":"Department of Medicine Aga Khan University  Karachi Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"crossref","unstructured":"Immunofluorescence detection of new antigen\u2010 antibody system (S\/anti\u20105) associated to hepatitis B virus in liver and in serum of HBsAg carriers.1977:997\u20101003.","DOI":"10.1136\/gut.18.12.997"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90207-3"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30298-X"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","unstructured":"ChenH ShenD JiD et al.Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta\u2010analysis.2019;68:512\u2010521. doi:10.1136\/gutjnl-2018-316601","DOI":"10.1136\/gutjnl-2018-316601"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318691"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz633"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.008"},{"key":"e_1_2_6_9_1","unstructured":"Global hepatitis report.World Health Organization;2017."},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.01.014"},{"key":"e_1_2_6_11_1","first-page":"647","article-title":"Hepatitis D virus: a call to screening","volume":"10","author":"Ahn J","year":"2014","journal-title":"Gastroenterol Hepatol"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06584-w"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2013.05.007"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/HEP.28279"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz001"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800"},{"key":"e_1_2_6_17_1","first-page":"157","article-title":"Advances in hepatitis D virus biology and disease","volume":"12","author":"Smedile A","year":"1994","journal-title":"Prog Liver Dis"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.3.420"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14729"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113533"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92497-3"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.7471\/CT.2014.1683"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14243"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2010.01329.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80185-8"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13604"},{"key":"e_1_2_6_27_1","unstructured":"Global health sector strategy on viral hepatitis 2016\u20102021. Towards ending viral hepatitis.2016."},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)90976-X"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198711123172004"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1086\/655808"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/INFDIS\/146.4.472"},{"issue":"6","key":"e_1_2_6_32_1","first-page":"622","article-title":"Seroepidemiology of hepatitis D (delta agent) and hepatitis B among Virginia state prisoners","volume":"9","author":"Tucker RM","year":"1987","journal-title":"Clin Ther"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JHEP.2020.06.038"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JCV.2021.104987"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/LIV.15106"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/IJERPH15071550"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/HEP.1840050205"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198506063122305"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1053\/JHIN.2001.1068"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268806007643"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11749-009-0177-3"},{"issue":"3","key":"e_1_2_6_42_1","first-page":"313","article-title":"Infezioni da HBV e HDV nei pazienti in trattamento emodialitico cronico","volume":"9","author":"Marinucci G","year":"1987","journal-title":"Riv Eur Sci Med Farmacol"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01644177"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-5-631"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-016-0956-1"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.21149\/11128"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.11604\/PAMJ.SUPP.2017.27.3.11981"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.15579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T03:32:17Z","timestamp":1693625537000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.15579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":46,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1111\/liv.15579"],"URL":"https:\/\/doi.org\/10.1111\/liv.15579","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"assertion":[{"value":"2022-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}